Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Monsanto Company (NYSE: MON) shares increased 2.15 percent to close at $115.23 a share Wednesday. The stock traded between $113.61 and $116.81 on volume 5.64 million shares traded. The company reported revenues were $3.1 billion for the first quarter of 2014, an increase of 7.0 percent when compared to a year ago. Shares of Monsanto have gained approximately 20.0 percent in the past year.
Get more information on Monsanto and free access to the in-depth equity report at:
www.FiveStarEquities.com/MON
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) shares gained 6.46 percent to close at $35.11 a share Wednesday. The stock traded between $30.08 and $35.20 on volume 5.88 million shares traded. The company announced that it expects net Gattex/Revestive sales to be in the range of $110.0 million and $120.0 million in 2014. Shares of NPS Pharmaceuticals have gained approximately 295.0 percent in the past year.
Get more information on NPS Pharmaceuticals free access to the in-depth equity report at:
www.FiveStarEquities.com/NPSP
RPM International Inc. (NYSE: RPM) shares gained 2.87 percent to close at $42.66 a share Wednesday. The stock traded between $41.39 and $43.00 on volume of 2.71 million shares traded. The company reported a net income of $63.6 million for the second quarter of fiscal 2014, an increase of 52.5 percent when compared to a year ago. Shares of RPM International have gained approximately 40.0 percent in the past year.
Get more information on RPM International and free access to the in-depth equity report at:
www.FiveStarEquities.com/RPM
Tenet Healthcare Corp. (NYSE: THC) shares declined 1.61 percent to close at $45.36 a share Wednesday. The stock traded between $44.24 and $46.10 on volume 3.82 million shares traded. Raymond James analyst John Ransom has downgraded his rating on the company to “market perform” from “outperform”. Shares of Tenet Healthcare have gained approximately 30.0 percent in the past year.
Get more information on Tenet Healthcare and free access to the in-depth equity report at:
www.FiveStarEquities.com/THC
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]